Lenalidomide for Newly Diagnosed MM and the Incidence of Second Primary Cancer
Palumbo A et al. Second primary malignancies in newly diagnosed multiple myeloma patients treated with lenalidomide: Analysis of pooled data in 2459 patients. Proc ASH 2011;Abstract 996.
Dr Richardson is Associate Professor of Medicine at Harvard Medical School and Clinical Director of the Jerome Lipper Center for Multiple Myeloma at Dana-Farber Cancer Institute in Boston, Massachusetts.
|